Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy.
Sidransky
E
E
Ginns
E I
EI
Westman
J A
JA
Ehmann
W C
WC
D000293:Adolescent; D000328:Adult; D004305:Dose-Response Relationship, Drug; D005598:Fractures, Spontaneous / Q000209:etiology*; D005776:Gaucher Disease / Q000150:complications* / Q000188:drug therapy*; D005962:Glucosylceramidase / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male
C070292:alglucerase; D005962:Glucosylceramidase